SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-15-006821
Filing Date
2015-11-09
Accepted
2015-11-09 16:05:35
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ctix_10q.htm 10-Q 332321
2 CERTIFICATION ctix_ex311.htm EX-31.1 7479
3 CERTIFICATION ctix_ex312.htm EX-31.2 7864
4 CERTIFICATION ctix_ex321.htm EX-32.1 2990
5 CERTIFICATION ctix_ex322.htm EX-32.2 3376
  Complete submission text file 0001477932-15-006821.txt   2370029

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctix-20150930.xml EX-101.INS 394554
7 XBRL TAXONOMY EXTENSION SCHEMA ctix-20150930.xsd EX-101.SCH 42084
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctix-20150930_cal.xml EX-101.CAL 46323
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctix-20150930_def.xml EX-101.DEF 87251
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctix-20150930_lab.xml EX-101.LAB 217583
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctix-20150930_pre.xml EX-101.PRE 167830
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37357 | Film No.: 151215598
SIC: 2834 Pharmaceutical Preparations